Eli Lilly and Company's (LLY) CEO Dave Ricks on Q1 2022 Results - Earnings Call Transcript

Eli Lilly and Company (NYSE:NYSE:LLY) Q1 2022 Earnings Conference Call April 28, 2022, 9:00 AM ET Company Participants Kevin Hern - Vice President, Investor Relations Dave Ricks - Chair and...

Related Keywords

Taiwan ,Japan ,United States ,China ,Boston ,Massachusetts ,Saudi Arabia ,Russia ,Canada ,Ukraine ,Russian ,Americans ,America ,American ,Robyn Karnauskas ,Mike Mason ,Dave Ricks ,Andrew Baum ,Tim Anderson ,Ilya Yuffa ,Eli Lilly ,Evan Seigerman ,Chris Shibutani ,Lauren Zierke ,Carter Gould ,Kevin Hern ,Terence Flynn ,Alice Nettleton ,Kerry Holford ,Geoff Meacham ,Steve Scala ,Anne White ,Kento Ueha ,Seamus Fernandez ,Dan Skovronsky ,Louise Chen ,Chris Schott ,Sara Smith ,Patrik Jonsson ,Jake Van Naarden ,Morgan Stanley ,Company Participants ,American Academy Of Dermatology Annual Meeting ,National Coverage Determination ,Goldman Sachs ,Boehringer Ingelheim ,Wolfe Research ,Barclays ,Data Monitoring Committee ,Lilly Institute For Genetic Medicines ,Exchange Commission ,Colitis Virtual Congress ,Elilly International ,Oncology Oncologic Drugs Advisory Committee ,Conference Call April ,Van Naarden ,Executive Officer ,Loxo Oncology ,Lilly Immunology ,Lilly United ,Vice President ,Anat Ashkenazi ,Chief Financial Officer ,Chief Scientific ,Medical Officer ,Lilly Neuroscience ,Lilly Oncology ,Lilly Diabetes ,Investor Relations ,Independent Data Monitoring Committee ,Use Authorization ,Lilly Institute ,Genetic Medicines ,Priority Review ,Europeans Crohn ,American Academy ,Dermatology Annual Meeting ,Drugs Advisory Committee ,Federal Health ,Umer Raffat ,Vamil Divan ,